Adapter-based allogeneic CAR T cells to overcome antigen escape in solid tumors.
Pham PQ, Sodji QH.Front Immunol. 2026 Apr 22;17:1822583. doi: 10.3389/fimmu.2026.1822583. eCollection 2026.PMID: 42099654 Free PMC article. Review.
Class I HDAC inhibition enhances the stem-like memory properties of CRISPR-engineered CAR T cells in neuroblastoma.
Cappabianca D, Toulany M, Zima S, Shea A, Vidugiriene J, Lauer A, Sylvester K, Gnanasekar V, Foster S, Turaga R, Saha K, Ayuso J, Sodji QH.Mol Ther Oncol. 2026 Apr 7;34(2):201200. doi: 10.1016/j.omton.2026.201200. eCollection 2026 Jun 18.PMID: 42058597 Free PMC article.
Y-box Binding Protein-1 at the Crossroads of DNA Damage Response and Tumor Immune Evasion.
Toulany M, Sodji QH.JNCI Cancer Spectr. 2026 Apr 24:pkag044. doi: 10.1093/jncics/pkag044. Online ahead of print.PMID: 42033033
Radiotherapy for Meningiomas: Molecular, Imaging, and Therapeutic Advances.
Eckelmann B, Morris B.Curr Oncol Rep. 2026 Apr 21;28(1):42. doi: 10.1007/s11912-026-01766-7.PMID: 42012576 Free PMC article. Review.
Convergent evolution of complex structural variants drives therapy resistance in metastatic prostate cancer.
Moreno-Rodriguez T, Zhang M, Lundberg A, Shrestha R, Sjöström M, Pasam A, Chan J, Devereux L, Foye A, Zhu X, Weinstein AS, Trigos AS, Wyatt AW, Alumkal JJ, Small EJ, Aggarwal R, Dehm SM, Bootsma ML, Zhao SG, Lupien M, Feng FY, Sandhu S, Quigley DA.Genome Biol. 2026 Apr 15. doi: 10.1186/s13059-026-04074-2. Online ahead of print.PMID: 41987223 Free article.
Deducing cardiorespiratory motion of cardiac substructures using a novel 5D-MRI workflow for radiotherapy.
Ruff C, Naren T, Wieben O, Nagpal P, Johnson K, Zhao J, Grist T, Baschnagel A, Glide-Hurst C.Phys Med Biol. 2026 Apr 29;71(9):095007. doi: 10.1088/1361-6560/ae5752.PMID: 41880763 Free PMC article.
A high-precision image-guided platform for studying spinal cord toxicity under ultra-high dose rate electron irradiation.
Zhou B, Guo L, Tsai YC, van der Kogel A, Wong JW, Iordachita I, Jiang K, Lu W, Medin PM, Wang KK.Phys Med Biol. 2026 Apr 8;71(7). doi: 10.1088/1361-6560/ae56cb.PMID: 41875551
Accelerated Partial Breast Irradiation: The Search for the Optimal Technique Continues.
Anderson B, Kirova Y.Int J Radiat Oncol Biol Phys. 2026 Apr 1;124(5):1248-1250. doi: 10.1016/j.ijrobp.2025.07.1441.PMID: 41856711 No abstract available.
Cisplatin during radiation for head and neck cancer: insights from NRG Oncology experience.
Sousa LG, Edward Bates J, Anand P, Caudell JJ, Colevas AD, Runge CL, Sharon JD, Awan M, Beadle BM, Choe JH, Gidley PW, Harari PM, Henson C, Katzel JA, Lee NY, McDowell L, Mell LK, Nader ME, Rudra S, Wang K, Yang G, Yom SS, Wise-Draper TM.J Natl Cancer Inst. 2026 Apr 1;118(4):655-668. doi: 10.1093/jnci/djaf343.PMID: 41344314 Free PMC article. Review.
Association of Prior PARP Inhibitor Exposure with Clinical Outcomes after 177Lu-PSMA-617 in Men with Castration-resistant Prostate Cancer and Mutations in DNA Homologous Recombination Repair Genes.
Raychaudhuri R, Tuchayi AM, Low SK, Arafa AT, Graham LS, Gulati R, Pritchard CC, Montgomery RB, Haffner MC, Nelson PS, Yu EY, Hawley JE, Cheng HH, Mo G, Chen DL, Antonarakis ES, Kilari D, Hope TA, Iravani A, Schweizer MT.Eur Urol Oncol. 2026 Apr;9(2):430-437. doi: 10.1016/j.euo.2025.01.002. Epub 2025 Feb 7.PMID: 39920014 Free PMC article.